Medical Design Technology -
25 Mar 2019 18:00
When patients with HIV who are also battling opioid dependence go without addiction treatment, they are more likely to stop taking their HIV medications than drug-free patients. While the daily oral form of naltrexone--a drug that blunts the effects of opioids... Contributed Author: University of Pennsylvania School of Medicine Topics: Implantables
Share this Article